Compile Data Set for Download or QSAR
Report error Found 379 Enz. Inhib. hit(s) with Target = '5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1'
LigandPNGBDBM240765(US9422312, 1)
Affinity DataEC50:  26nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240766(US9422312, 2)
Affinity DataEC50:  20nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240767(US9422312, 3)
Affinity DataEC50:  94nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240768(US9422312, 4)
Affinity DataEC50:  52nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240769(US9422312, 5)
Affinity DataEC50:  15nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240770(US9422312, 6)
Affinity DataEC50:  54nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240771(US9422312, 7)
Affinity DataEC50:  37nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240772(US9422312, 8)
Affinity DataEC50:  61nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240773(US9422312, 9)
Affinity DataEC50:  89nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240774(US9422312, 10)
Affinity DataEC50:  17nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240775(US9422312, 11)
Affinity DataEC50:  62nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240776(US9422312, 12)
Affinity DataEC50:  2nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240777(US9422312, 13)
Affinity DataEC50:  30nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240778(US9422312, 14)
Affinity DataEC50:  52nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240779(US9422312, 15)
Affinity DataEC50:  90nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240780(US9422312, 16)
Affinity DataEC50:  48nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240785(US9422312, 17)
Affinity DataEC50:  202nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240781(US9422312, 18)
Affinity DataEC50:  67nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240782(US9422312, 19)
Affinity DataEC50:  138nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240783(US9422312, 20)
Affinity DataEC50:  82nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM240784(US9422312, 21)
Affinity DataEC50:  2.90E+3nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237920(US9394285, 1)
Affinity DataEC50:  4.20nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237921(US9394285, 2)
Affinity DataEC50:  64.7nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237922(US9394285, 3)
Affinity DataEC50:  459nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237923(US9394285, 4)
Affinity DataEC50:  71nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237924(US9394285, 5)
Affinity DataEC50:  35.7nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237925(US9394285, 6)
Affinity DataEC50:  17.3nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237926(US9394285, 7)
Affinity DataEC50:  671nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237927(US9394285, 8)
Affinity DataEC50:  220nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237928(US9394285, 9)
Affinity DataEC50:  71.2nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237929(US9394285, 10)
Affinity DataEC50:  69.9nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237930(US9394285, 11)
Affinity DataEC50:  554nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237931(US9394285, 12)
Affinity DataEC50:  42.5nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237932(US9394285, 13)
Affinity DataEC50:  6.90nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237933(US9394285, 14B | US9394285, 14A | US9394285, 14)
Affinity DataEC50:  151nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237933(US9394285, 14B | US9394285, 14A | US9394285, 14)
Affinity DataEC50:  101nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237933(US9394285, 14B | US9394285, 14A | US9394285, 14)
Affinity DataEC50:  118nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237934(US9394285, 15)
Affinity DataEC50:  632nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237935(US9394285, 16)
Affinity DataEC50:  412nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237936(US9394285, 17)
Affinity DataEC50:  126nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237937(US9394285, 18)
Affinity DataEC50:  182nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237938(US9394285, 19)
Affinity DataEC50:  383nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237939(US9394285, 20)
Affinity DataEC50:  53.6nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237940(US9394285, 21)
Affinity DataEC50:  93.5nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237941(US9394285, 22)
Affinity DataEC50:  13.7nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237942(US9394285, 23)
Affinity DataEC50:  16nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237943(US9394285, 24)
Affinity DataEC50:  252nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237944(US9394285, 25)
Affinity DataEC50:  111nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM60975(4,6-difluoro-5-[4-(1-hydroxy-2-methylpropan-2-yl)p...)
Affinity DataEC50:  125nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM237946(US9394285, 27)
Affinity DataEC50:  36.9nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 379 total ) | Next | Last >>
Jump to: